IFPMA congratulates GAVI Alliance on
10 years of saving lives; welcomes 
BMGF call for new ‘Decade of Vaccines’ 

European Vaccine Manufacturers’ Contribution
to Council of Europe Hearing
on H1N1 Pandemic

IFPMA Statement to WHO Executive Board
on Pandemic Preparedness

GlaxoSmithKline strengthens Partnerships for
Developing World Health

Haiti: R&D Pharmaceutical Industry
Emergency Aid exceeds $16.9 million

IFPMA appoints New Director of
Intellectual Property and Trade

New Industry Position Requires Disclosure of
All Clinical Trials in Patients

IFPMA Appoints Mr. Eduardo Pisani as
New Director General

Mr. Haruo Naito Confirmed as
New President of the IFPMA

GlaxoSmithKline and Pfizer launch
ViiV Healthcare joint venture for HIV/AIDS

WHO/UNICEF/World Bank SOWVI Report: “Vaccine Development Worldwide is Booming”

IFPMA Issue Brief: Counterfeit Medicines
- a Global Public Health Risk

Industry Emergency Aid after Natural Disasters across Asia & the Pacific

IFPMA salutes Québec’s new Biopharmaceutical Strategy